Загрузка...
Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors
The modified vaccinia virus Ankara (MVA) strain, which has been developed as a vaccine against smallpox, is since the nineties widely tested in clinical trials as recombinant vector for vaccination or gene therapy applications. Although MVA is renowned for its safety, several biosafety aspects need...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Bentham Science Publishers
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4031919/ https://ncbi.nlm.nih.gov/pubmed/24397528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/156652321306140103221941 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|